GARDEN CITY, N.Y., Feb. 26, 2020 /PRNewswire/ -- The Mollie Biggane Melanoma Foundation (Garden City, New York) and the AIM at Melanoma Foundation ...

An investigational mRNA vaccine used along with immunotherapy continues to show benefit for people with high-risk forms of the skin cancer melanoma, the drugmakers said Thursday.